EI
MXCT icon

EFG International’s MaxCyte MXCT Stock Holding History

EFG International’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56K Hold
1,261
– – ﹤0.01% 1066
2026
Q1 		$886 Hold
1,261
– – ﹤0.01% 1024
2025
Q4 		$1.96K Buy
+1,261
New +$2.01K ﹤0.01% 847

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

EFG International's MXCT Position: Q2 2026 in Review

EFG International held its MaxCyte (MXCT) position steady in Q2 2026 at 1,261 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #1066.

EFG International first reported a position in MXCT in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.96K in Q4 2025. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • EFG International held 1,261 shares of MaxCyte worth $1.56K as of Q2 2026.
  • EFG International left its MaxCyte share count unchanged in Q2 2026.
  • MaxCyte made up ﹤0.01% of EFG International's portfolio in Q2 2026, its #1066 holding.
  • EFG International first reported a position in MaxCyte in Q4 2025 and has held it in 3 quarters since.
  • EFG International's MaxCyte position peaked at $1.96K in Q4 2025.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.